Clinical Scorecard: Case Report on Thoracoscopic Resection of a Myxoma in the Left Ventricle

At a Glance

Key Highlights

• Cardiac myxoma is the most common primary benign cardiac tumor.
• Left ventricular myxomas are rare, accounting for 2%-3% of cases.
• Surgical resection is the preferred treatment to prevent recurrence.
• Multimodal imaging is crucial for accurate diagnosis and surgical planning.
• Video-assisted thoracoscopic surgery (VATS) can be a safe approach for resection.
• Misdiagnosis as left ventricular thrombus can lead to delayed treatment.

Guideline-Based Recommendations

Diagnosis

• Use transthoracic echocardiography (TTE) for initial visualization.
• Consider cardiac magnetic resonance (CMR) imaging for complex cases.
• Utilize myocardial contrast echocardiography (MCE) for assessing LV myxoma perfusion.

Management

• Surgical resection is the main treatment for cardiac myxomas.

Monitoring & Follow-up

• Monitor for complications such as embolism and heart failure post-surgery.

Risks

• Potential for misdiagnosis as left ventricular thrombus, leading to delayed treatment.

Patient & Prescribing Data

Successful thoracoscopic resection under cardiopulmonary bypass with good prognosis.

Clinical Best Practices

• Employ multimodal imaging to confirm diagnosis and assess tumor characteristics.
• Utilize VATS for minimally invasive surgical approaches when feasible.
• Maintain careful intraoperative monitoring to avoid complications.

Related Resources & Content

• Case Report on Thoracoscopic Resection of a Myxoma in the Left Ventricle